Judge rejects Mylan lawsuit against FDA over generic of Diovan

12/28/2012 | Bloomberg

U.S. District Court Judge John D. Bates dismissed Mylan's lawsuit against the FDA over the rejection of a generic form of Novartis AG's heart drug Diovan. Bates said the FDA didn't act in a capricious manner and "[g]iven Mylan's status as a leading generic manufacturer and its already-large market presence, the potential financial impact on Mylan's business is too small to support a finding of irreparable harm."

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC